Hydroxychloroquine and azithromycin alter the contractility of living porcine heart slices

The cardiotoxicity risk of hydroxychloroquine (HCQ) and azithromycin (AZM) has been the subject of intensive research triggered by safety concerns in COVID-19 patients. HCQ and AZM have been associated with QT interval prolongation and drug-induced arrhythmias, however other cardiotoxicity mechanism...

Full description

Saved in:
Bibliographic Details
Main Authors: Qin Wu (Author), Abigail J. Ross (Author), Tugce Ipek (Author), Georgina H. Thompson (Author), Robert D. Johnson (Author), Changhao Wu (Author), Patrizia Camelliti (Author)
Format: Book
Published: Frontiers Media S.A., 2023-05-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000 am a22000003u 4500
001 doaj_b6da9934a8844a17b964cae91e0b70e9
042 |a dc 
100 1 0 |a Qin Wu  |e author 
700 1 0 |a Qin Wu  |e author 
700 1 0 |a Abigail J. Ross  |e author 
700 1 0 |a Tugce Ipek  |e author 
700 1 0 |a Georgina H. Thompson  |e author 
700 1 0 |a Robert D. Johnson  |e author 
700 1 0 |a Changhao Wu  |e author 
700 1 0 |a Patrizia Camelliti  |e author 
245 0 0 |a Hydroxychloroquine and azithromycin alter the contractility of living porcine heart slices 
260 |b Frontiers Media S.A.,   |c 2023-05-01T00:00:00Z. 
500 |a 1663-9812 
500 |a 10.3389/fphar.2023.1127388 
520 |a The cardiotoxicity risk of hydroxychloroquine (HCQ) and azithromycin (AZM) has been the subject of intensive research triggered by safety concerns in COVID-19 patients. HCQ and AZM have been associated with QT interval prolongation and drug-induced arrhythmias, however other cardiotoxicity mechanisms remain largely unexplored. Our group has pioneered the living heart slice preparation, an ex-vivo platform that maintains native cardiac tissue architecture and physiological electrical and contractile properties. Here, we evaluated the cardiotoxic effect of HCQ and AZM applied alone or in combination on cardiac contractility by measuring contractile force and contraction kinetics in heart slices prepared from porcine hearts. Our results show that clinically relevant concentrations of HCQ monotherapy (1-10 µM) reduced contractile force and contraction kinetics in porcine slices in a dose-dependent manner. However, AZM monotherapy decreased contractile force and contraction kinetics only at higher concentrations (30 µM). Combination of HCQ and AZM induced a dose-dependent effect similar to HCQ alone. Furthermore, pre-treating porcine heart slices with the L-type calcium channel agonist Bay K8644 prevented the effect of both drugs, while administration of Bay K8644 after drugs interventions largely reversed the effects, suggesting a mechanism involving inhibition of L-type calcium channels. These findings indicate that HCQ and AZM alter cardiac function beyond QT prolongation with significant contractile dysfunction in intact cardiac tissue. Our porcine heart slices provide a powerful platform to investigate mechanisms of drug cardiotoxicity. 
546 |a EN 
690 |a myocardial slices 
690 |a organotypic ex-vivo models 
690 |a COVID-19 
690 |a cardiotoxicity 
690 |a safety pharmacology 
690 |a calcium channels 
690 |a Therapeutics. Pharmacology 
690 |a RM1-950 
655 7 |a article  |2 local 
786 0 |n Frontiers in Pharmacology, Vol 14 (2023) 
787 0 |n https://www.frontiersin.org/articles/10.3389/fphar.2023.1127388/full 
787 0 |n https://doaj.org/toc/1663-9812 
856 4 1 |u https://doaj.org/article/b6da9934a8844a17b964cae91e0b70e9  |z Connect to this object online.